This export of mitochondrial aspartate into the cytosol is mediated by the mitochondrial aspartate-glutamate carrier 1 (AGC1), and genetic inhibition of AGC1 compromises xenograft tumor growth when a glutaminase inhibitor is used. Here, GLS is linked to neoplasm.